Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

19
Number of overlapping holdings
17.0%
% of IXJ's 113 holdings also in GDOC
51.4%
% of GDOC's 39 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IXJ |
Weight in GDOC |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 8.8% | 9.7% | 8.8% | |
UNITEDHEALTH GROUP INC | 6.5% | 5.2% | 5.2% | |
ABBVIE INC | 4.7% | 6.4% | 4.7% | |
ABBOTT LABORATORIES | 3.1% | 5.2% | 3.1% | |
ASTRAZENECA PLC | 3.1% | 4.2% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to GDOC
JOHNSON & JOHNSON | 5.4% | |
ROCHE HOLDING LTD | 3.3% | |
NOVARTIS AG | 3.0% | |
THERMO FISHER SCIENTIFIC INC | 2.6% | |
AMGEN INC | 2.3% | |
PFIZER INC | 2.0% | |
GILEAD SCIENCES INC | 1.9% | |
VERTEX PHARMACEUTICALS INC | 1.7% | |
STRYKER CORP | 1.7% | |
SANOFI-AVENTIS | 1.7% |
IXJ Underweight Relative to GDOC
BOSTON SCIENTIFIC CORP | -6.3% | |
INSULET CORP | -4.2% | |
COOPER COS INC/THE | -3.5% | |
INTUITIVE SURGICAL INC | -3.4% | |
BIOMARIN PHARMACEUTICAL INC | -3.3% | |
VEEVA SYSTEMS INC-CLASS A | -2.5% | |
ARGENX SE ADR | -2.3% | |
LONZA GROUP AG-REG | -2.3% | |
ABBOTT LABORATORIES | -2.2% | |
NEUROCRINE BIOSCIENCES INC | -2.1% |